Quantinuum boosts its IPO to $1.46 billion as orders hit double-digit multiples of available shares

The Honeywell-backed quantum computing company raised both its share count and price range after massive oversubscription, targeting a $14.3 billion market value on $31 million in annual revenue


Quantinuum boosts its IPO to $1.46 billion as orders hit double-digit multiples of available shares

TL;DR

Quantinuum boosted its IPO to $1.46 billion after double-digit oversubscription, raising the price range to $53-55 per share and targeting a $14.3 billion valuation. The Honeywell-backed quantum computing company reported $31 million in 2025 revenue and is set to begin trading Thursday.

Quantinuum, the Honeywell-backed quantum computing company, has increased the size of its initial public offering to as much as $1.46 billion after demand from investors far exceeded the original allocation. The company is now offering 26.5 million shares at $53 to $55 each, up from a previous range of approximately 21 million shares at $45 to $50. At the top of the new range, Quantinuum would enter the public market with a valuation of $14.3 billion.

The IPO drew orders for a double-digit multiple of the shares available, according to people familiar with the matter. Quantinuum is on track to price after the market closes in New York on Wednesday and begin trading on the Nasdaq Global Market under the symbol QNT on Thursday. It would be the first pure-play quantum computing hardware company to list on a major US exchange.

The valuation question

The numbers behind the $14.3 billion valuation are unusual even by the standards of frontier technology IPOs. Quantinuum reported $30.9 million in revenue for 2025, $79.3 million in bookings, and a net loss of $192.6 million. At the top of the IPO range, the company would be valued at roughly 462 times its last annual revenue, a multiple that only makes sense as a bet on quantum computing’s commercial future rather than its present economics.

The 💜 of EU tech

The latest rumblings from the EU tech scene, a story from our wise ol' founder Boris, and some questionable AI art. It's free, every week, in your inbox. Sign up now!

The company develops trapped-ion quantum computers, a technology that uses individual ions held in electromagnetic fields as qubits. Quantinuum’s System Model H2 is among the highest-performing quantum processors commercially available, and the company is building platforms for applications in chemistry, machine learning, cybersecurity, finance, and drug discovery. Governments worldwide are investing heavily in quantum computing, with France committing €500 million and launching the PROQCIMA initiative to develop fault-tolerant quantum machines.

US government backing

The Trump administration provided a direct catalyst for Quantinuum’s IPO momentum. On 21 May, the government announced more than $2 billion in funding for nine quantum computing firms in the US, with Quantinuum set to receive $100 million in exchange for an equity stake. The announcement sent quantum-related stocks sharply higher and established a policy framework that treats quantum computing as a strategic national capability.

IBM, which also received government funding under the programme, saw its shares surge on the news. The broader quantum computing sector has benefited from a shift in institutional sentiment, moving from speculative curiosity to a category that governments and large enterprises are actively funding. European governments are also pouring public funds into quantum technology, creating a global competition for quantum capability that benefits companies like Quantinuum regardless of which region leads.

Honeywell’s quantum play

Quantinuum was formed in 2021 by merging Honeywell’s quantum computing division with Cambridge Quantum, a UK-based quantum software company. Honeywell will retain approximately 48.1% of the combined voting power after the IPO, maintaining effective control of the company while giving it access to public market capital for the first time.

The structure is notable because it means Quantinuum’s largest shareholder is a $150 billion industrial conglomerate with deep pockets, not a venture capital firm looking for a quick exit. Honeywell’s continued involvement provides both credibility and a built-in enterprise customer base, as the parent company can integrate quantum computing capabilities into its aerospace, building technologies, and industrial automation businesses.

The company is headquartered in Broomfield, Colorado, and maintains significant operations in the UK, where Cambridge Quantum’s team continues to develop quantum software and applications. Military and defence organisations across Europe and the US are among the early customers exploring quantum computing for cryptography, simulation, and optimisation problems that classical computers cannot efficiently solve.

What the oversubscription signals

The double-digit oversubscription is the most telling data point in the filing. Institutional investors are placing large orders for a company that lost six times more than it earned last year, in a technology category that is years away from broad commercial deployment. The willingness to pay 462 times revenue reflects a belief that quantum computing will follow the AI trajectory, moving from academic curiosity to transformative commercial capability faster than consensus expects.

Whether that belief is warranted remains contested. Analysts project massive growth for the quantum sector, but the timeline for fault-tolerant quantum computers capable of solving commercially relevant problems at scale remains uncertain. Quantinuum’s bookings growth, from $30.9 million in revenue to $79.3 million in bookings, suggests accelerating demand, but the gap between interest and revenue-generating deployment is still wide.

The IPO will test whether the public market agrees with the private market’s enthusiasm. If QNT trades well on Thursday, it will validate quantum computing as an investable category and likely accelerate IPO plans for other quantum firms. If it struggles, it will raise questions about whether frontier technology valuations have outrun the underlying science.

Get the TNW newsletter

Get the most important tech news in your inbox each week.